Medicus Pharma (MDCX) Stock Price, News & Analysis

Company Overview

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Key Stats

• Today's Range: $2.45 to $2.75
• 50-Day Range: $2.45 to $7.78
• 52-Week Range: $1.80 to $8.94
• Volume: 181,418 shs
• Average Volume: 398,361 shs
• Market Capitalization: $33.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $23.50
• Consensus Rating: Strong Buy

Medicus Pharma Stock Analysis - MarketRank™

Medicus Pharma scored higher than 27% of companies evaluated by MarketBeat, and ranked 749th out of 926 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Medicus Pharma has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Medicus Pharma has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Medicus Pharma are expected to decrease in the coming year, from ($1.14) to ($1.53) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medicus Pharma is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medicus Pharma is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Medicus Pharma has a P/B Ratio of 8.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for MDCX.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medicus Pharma does not currently pay a dividend.

Dividend Growth

Medicus Pharma does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for MDCX.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 5 people have searched for MDCX on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.

MarketBeat Follows

5 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Medicus Pharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $579,000.00 in company stock.

MDCX Stock Analysis - Frequently Asked Questions

How have MDCX shares performed this year?

Medicus Pharma's stock was trading at $2.43 at the beginning of 2025. Since then, MDCX shares have increased by 2.5% and is now trading at $2.49.
View the best growth stocks for 2025 here.

How were Medicus Pharma's earnings last quarter?

Medicus Pharma Ltd (NASDAQ:MDCX) issued its quarterly earnings results on Monday, May, 12th. The company reported ($0.42) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $0.19.

When did Medicus Pharma IPO?

Medicus Pharma (MDCX) raised $4 million in an initial public offering (IPO) on Thursday, November 14th 2024. The company issued 1,000,000 shares at $4.13 per share. Maxim Group LLC acted as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Who are Medicus Pharma's major shareholders?

Medicus Pharma's top institutional investors include Interchange Capital Partners LLC (12.39%), Armistice Capital LLC (9.43%) and Private Advisor Group LLC (0.42%).
View institutional ownership trends.

How do I buy shares of Medicus Pharma?

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/12/2025
• Today: 6/22/2025
• Next Earnings (Estimated): 6/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:MDCX
• Previous Symbol: NASDAQ:MDCX
• CIK: 1997296
• Web: www.medicuspharma.com
• Phone: 732-300-3046
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $23.50
• High Stock Price Target: $27.00
• Low Stock Price Target: $20.00
• Potential Upside/Downside: +843.8%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.16)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.16 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -380.03%
• Return on Assets: -224.22%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.53
• Quick Ratio: 1.53

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.29 per share
• Price / Book: 8.59

Miscellaneous

• Outstanding Shares: 13,570,000
• Free Float: N/A
• Market Cap: $33.79 million
• Optionable: N/A
• Beta: N/A